Research ArticleDrug Discovery and Translational Medicine
A tumor cell-selective inhibitor of mitogen-activated protein kinase phosphatases sensitizes breast cancer cells to lymphokine-activated killer cell activity
Christof T Kaltenmeier, Laura L Vollmer, Lawrence A Vernetti, Lindsay Caprio, Keanu Davis, Vasiliy N Korotchenko, Billy W Day, Michael Tsang, Keren I Hulkower, Michael T Lotze and Andreas Vogt
Journal of Pharmacology and Experimental Therapeutics February 2, 2017, jpet.116.239756; DOI: https://doi.org/10.1124/jpet.116.239756
